Jessica Weiss

1.2k total citations
55 papers, 753 citations indexed

About

Jessica Weiss is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jessica Weiss has authored 55 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jessica Weiss's work include Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (9 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Jessica Weiss is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (9 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Jessica Weiss collaborates with scholars based in Canada, United States and Switzerland. Jessica Weiss's co-authors include Renata Forste, Alberto Traverso, Mattea Welch, David A. Jaffray, Kathy Han, Christine Guntermann, Wei Shen, Jin Ye, Xiuqun Gong and Melania Pintilie and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and PEDIATRICS.

In The Last Decade

Jessica Weiss

49 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Weiss Canada 14 201 191 185 172 100 55 753
Michelle Moghadassi United States 18 227 1.1× 200 1.0× 115 0.6× 158 0.9× 116 1.2× 31 1.0k
Corina van den Hurk Netherlands 20 221 1.1× 594 3.1× 219 1.2× 133 0.8× 27 0.3× 74 1.2k
Jonathan Klein United States 14 168 0.8× 199 1.0× 113 0.6× 247 1.4× 38 0.4× 40 900
Moon‐Sing Lee Taiwan 19 62 0.3× 225 1.2× 139 0.8× 243 1.4× 47 0.5× 65 961
Maria Olsen Netherlands 12 44 0.2× 318 1.7× 135 0.7× 112 0.7× 89 0.9× 20 923
Jeroen Mebis Belgium 19 320 1.6× 448 2.3× 119 0.6× 261 1.5× 38 0.4× 65 973
Fouad Aoun Belgium 18 187 0.9× 204 1.1× 56 0.3× 690 4.0× 32 0.3× 99 1.2k
Anna Zygogianni Greece 15 109 0.5× 212 1.1× 49 0.3× 161 0.9× 33 0.3× 86 722
Veronika Weyer Germany 17 74 0.4× 183 1.0× 130 0.7× 55 0.3× 64 0.6× 35 723
Irene Karam Canada 19 320 1.6× 265 1.4× 102 0.6× 272 1.6× 14 0.1× 96 836

Countries citing papers authored by Jessica Weiss

Since Specialization
Citations

This map shows the geographic impact of Jessica Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Weiss more than expected).

Fields of papers citing papers by Jessica Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Weiss. The network helps show where Jessica Weiss may publish in the future.

Co-authorship network of co-authors of Jessica Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Weiss. A scholar is included among the top collaborators of Jessica Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Weiss. Jessica Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathew, John, Zeynep Baskurt, Meredith Giuliani, et al.. (2025). Changes in unmet needs after treatment for head and neck cancers – A prospective longitudinal cohort study. Oral Oncology. 163. 107250–107250. 1 indexed citations
2.
Gupta, Harsh, et al.. (2025). Longitudinal retrospective study of real-world adherence to colorectal cancer screening before and after the COVID-19 pandemic in the USA. BMJ Public Health. 3(1). e001734–e001734. 1 indexed citations
3.
Battat, Robert, Parul Tandon, Robert E. Ward, et al.. (2025). P1212 Effectiveness of Vedolizumab to Reduce Bowel Urgency in a Canadian Real-World Ulcerative Colitis Cohort. Journal of Crohn s and Colitis. 19(Supplement_1). i2192–i2193.
4.
5.
Adatia, Adil, Dawn Goodyear, Chrystyna Kalicinsky, et al.. (2024). Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in Canada. Allergy Asthma and Clinical Immunology. 20(1). 50–50. 3 indexed citations
6.
Kalyvas, Aristotelis, Kaiyun Yang, Barbara‐Ann Millar, et al.. (2024). Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases. Clinical and Translational Radiation Oncology. 45. 100723–100723.
7.
Weiss, Jessica, Zhihui Amy Liu, Anna Mary Nyakabau, et al.. (2023). Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO Global Oncology. 9(9). e2200127–e2200127. 9 indexed citations
8.
Weiss, Jessica, Bouchra Tawk, Fábio Ynoe de Moraes, et al.. (2023). Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey. JCO Global Oncology. 9(9). e2300046–e2300046. 4 indexed citations
9.
Fung, Andrea S., Jessica Weiss, Geoffrey Liu, et al.. (2023). Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies. JTO Clinical and Research Reports. 4(10). 100562–100562. 4 indexed citations
10.
Shibahara, Yukiko, Osvaldo Espin‐Garcia, James Conner, et al.. (2022). Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma. Cureus. 14(1). e21021–e21021. 2 indexed citations
11.
Yang, Kaiyun, Alexander Landry, Matthias Millesi, et al.. (2022). Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?. Journal of Neuro-Oncology. 157(1). 157–163. 1 indexed citations
12.
Weiss, Jessica, et al.. (2022). Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus. Frontiers in Immunology. 12. 761395–761395. 11 indexed citations
13.
Barry, Aisling, Joelle Helou, Andrea Bezjak, et al.. (2021). Quality of Life Outcomes Following Stereotactic Body Radiotherapy in Patients with Oligo-Metastatic Disease: A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics. 111(3). e166–e167.
14.
Weiss, Jessica, Nhu‐An Pham, Sebastião N. Martins-Filho, et al.. (2021). Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts. Translational Oncology. 14(10). 101179–101179. 16 indexed citations
15.
Yan, Michael, Patricia Lindsay, Jessica Weiss, et al.. (2021). Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre. Clinical and Translational Radiation Oncology. 30. 43–49. 10 indexed citations
16.
Traverso, Alberto, Mattea Welch, Jessica Weiss, et al.. (2019). Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients. Radiotherapy and Oncology. 143. 88–94. 55 indexed citations
17.
Welch, Mattea, Jessica Weiss, Melania Pintilie, et al.. (2019). Repeatability and reproducibility of MRI-based radiomic features in cervical cancer. Radiotherapy and Oncology. 135. 107–114. 114 indexed citations
18.
Weiss, Jessica, Klemens Kaupmann, Joerg Kallen, et al.. (2017). Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo. PLoS ONE. 12(11). e0188391–e0188391. 46 indexed citations
19.
Haddad, Robert I., Tanguy Y. Seiwert, David G. Pfister, et al.. (2016). Pembrolizumab after progression on platinum and cetuximab in head and neck squamous cell carcinoma (HNSCC): results from KEYNOTE-055. Annals of Oncology. 27. vi330–vi330. 11 indexed citations
20.
Åhlström, Håkan, Bo Lennernäs, Anna Tolf, et al.. (2014). 982 Local antiandrogen therapy, a novel treatment strategy for localized prostate cancer. European Urology Supplements. 13(1). e982–e982. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Moghadassi Breakdown of academic impact, for papers by Corina van den Hurk Breakdown of academic impact, for papers by Jonathan Klein Breakdown of academic impact, for papers by Moon‐Sing Lee Breakdown of academic impact, for papers by Maria Olsen Breakdown of academic impact, for papers by Jeroen Mebis Breakdown of academic impact, for papers by Fouad Aoun Breakdown of academic impact, for papers by Anna Zygogianni Breakdown of academic impact, for papers by Veronika Weyer Breakdown of academic impact, for papers by Irene Karam
Rankless by CCL
2026